Evolution, controversies and the future of prostate cancer grading

2019 ◽  
Vol 69 (2) ◽  
pp. 55-66 ◽  
Author(s):  
Lars Egevad ◽  
Brett Delahunt ◽  
John Yaxley ◽  
Hemamali Samaratunga
2020 ◽  
Author(s):  
Lars Egevad ◽  
Brett Delahunt ◽  
David G. Bostwick ◽  
Liang Cheng ◽  
Andrew J. Evans ◽  
...  

2007 ◽  
Vol 177 (4S) ◽  
pp. 250-250
Author(s):  
Thomas M. Fandel ◽  
Maria Pfnuer ◽  
Claudia Corinth ◽  
Michael Ansorge ◽  
Sebastian W. Melchior ◽  
...  

2020 ◽  
Vol 28 (3) ◽  
pp. 399-405
Author(s):  
Fabrizio Fontana ◽  
Olga A. Babenko

Aim of this letter is to attract the attention of journal readers to the study of exosomes as an important direction in the development of Oncology, in particular, in the diagnosis and treatment of prostate cancer. Exosomes are produced by tumor cells and regulate proliferation, metastasis, and the development of chemoresistance. Their extraction from biological fluids allows further use of these vesicles as potential biomarkers of prostate cancer. In the future, exosomes can be successfully used in the delivery of drugs and other anti-tumor substances to cancer cells.


Diagnostics ◽  
2021 ◽  
Vol 11 (5) ◽  
pp. 908
Author(s):  
Felice Crocetto ◽  
Biagio Barone ◽  
Vincenzo Francesco Caputo ◽  
Matteo Fontana ◽  
Ottavio de Cobelli ◽  
...  

Prostate cancer (PCa) is the second most common neoplasm in men and the fifth leading cause of death worldwide [...]


2004 ◽  
Vol 37 (7) ◽  
pp. 519-528 ◽  
Author(s):  
Stephen D. Mikolajczyk ◽  
Yong Song ◽  
James R. Wong ◽  
Robert S. Matson ◽  
Harry G. Rittenhouse

2017 ◽  
Vol 71 (6) ◽  
pp. 907-912 ◽  
Author(s):  
Won Sik Ham ◽  
Heather J. Chalfin ◽  
Zhaoyong Feng ◽  
Bruce J. Trock ◽  
Jonathan I. Epstein ◽  
...  

The Prostate ◽  
2015 ◽  
Vol 76 (5) ◽  
pp. 427-433 ◽  
Author(s):  
Oleksandr N. Kryvenko ◽  
Jonathan I. Epstein

Sign in / Sign up

Export Citation Format

Share Document